4
Tetrahedron Letters
Scheme 2. The regioselectivity of this protocol
2. Na, Y. J. Pharm. Pharmacol. 2009, 61, 707-712.
The proposed mechanism of the intramolecular cyclization is
shown in Scheme 3. The conversion started with the oxidative-
addition of Pd (0) to give intermediate I with the release of N2.
3. (a) Cheng, J.-H.; Huang, A. M.; Hour, T.-C.; Yang, S.-C.; Pu, Y.-S.; Lin,
C.-N. Eur. J. Med. Chem. 2011, 46, 1222-1231; (b) Mahabusarakam, W.;
Proudfoot, J.; Taylor, W.; Croft, K. Free Radic. Res. 2000, 33, 643-659.
4. Lin, C. N.; Hsieh, H. K.; Liou, S. J.; Ko, H. H.; Lin, H. C.; Chung, M. I.;
Ko, F. N.; Liu, H. W.; Teng, C. M. J. Pharm. Pharmacol. 1996, 48, 887-
890.
The insertion of CO gave intermediate Ⅱ and then generated the
intermediate Ⅲ in the presence of K2CO3, subsequent reductive
elimination gave the xanthone and Pd (0), which can be used in
the next catalytic cycle.
5. Nakatani, K.; Nakahata, N.; Arakawa, T.; Yasuda, H.; Ohizumi, Y.
Biochem. Pharmacol. 2002, 63, 73-79.
Scheme 3. Proposed mechanism
6. Nakatani, K.; Atsumi, M.; Arakawa, T.; Oosawa, K.; Shimura, S.;
Nakahata, N.; Ohizumi, Y. Biol. Pharm. Bull. 2002, 25, 1137-1141.
7. (a) Zou, Y.; Zhao, Q.; Hu, H.; Hu, L.; Yu, S.; Xu, M.; Wu, Q. Arch.
Pharmacal Res. 2012, 35, 2093-2104; (b) Pouli, N. M., Panagiotis Anti-
Cancer Agents in Med. Chem. 2009, 9, 77-98.
8. Saleem, M.; Nazir, M.; Ali, M. S.; Hussain, H.; Lee, Y. S.; Riaz, N.;
Jabbar, A. Nat. Prod. Rep. 2010, 27, 238-254.
9. (a) Chen, S. X.; Wan, M.; Loh, B. N. Planta Med. 1996, 62, 381-382; (b)
Shen, Y. C.; Wang, L. T.; Khalil, A. T.; Chiang, L. C.; Cheng, P. W.
Chem. Pharm. Bull. 2005, 53, 244-247.
10. (a) Rath, G.; Potterat, O.; Mavi, S.; Hostettmann, K. Phytochemistry
1996, 43, 513-520(b) Gopalakrishnan, G.; Banumathi, B.; Suresh, G. J.
Nat. Prod. 1997, 60, 519-524.
11. Grover, P. K.; Shah, G. D.; Shah, R. C. J. Chem. Soc. 1955, 3982-3985.
12. (a) Quillinan, A. J.; Scheinmann, F. J. Chem. Soc., Perkin Trans. 1 1973,
1329-1337; (b) Barbero, N.; SanMartin, R.; Domínguez, E. Tetrahedron
2009, 65, 5729-5732; (c) Hintermann, L.; Masuo, R.; Suzuki, K. Org.
Lett. 2008, 10, 4859-4862; (d) Johnson, M. M.; Naidoo, J. M.;
Fernandes, M. A.; Mmutlane, E. M.; van Otterlo, W. A. L.; de Koning,
C. B. J. Org. Chem. 2010, 75, 8701-8704; (e) Shan, G.; Han, X.; Lin, Y.;
Yu, S.; Rao, Y. Org. Biomol. Chem. 2013, 11, 2318-2322.
13. (a) Giri, R.; Goodell, J. R.; Xing, C.; Benoit, A.; Kaur, H.; Hiasa, H.;
Ferguson, D. M. Bioorg. Med. Chem. 2010, 18, 1456-1463; (b) Lan, K.;
Fen, S.; Shan, Z. Aust. J. Chem. 2007, 60, 80-82; (c) Li, J.; Jin, C.; Su,
W. Heterocycles 2011, 83, 855-866; (d) Jackson, W. T.; Boyd, R. J.;
Froelich, L. L.; Gapinski, D. M.; Mallett, B. E.; Sawyer, J. S. J. Med.
Chem. 1993, 36, 1726-1734; (e) Olah, G. A.; Mathew, T.; Farnia, M.;
Prakash, G. K. S. Synlett 1999, 1067-1068; (f) Familoni, O. B.; Ionica, I.;
Bower, J. F.; Snieckus, V. Synlett 1997, 1081-1083.
In conclusion, we have developed
a Pd (0)-catalyzed
intramolecular carbonylation/C–H activation of ortho diazonium
salts of diphenyl ethers to form xanthones. By using easily
available ortho diazonium salts of diphenyl ethers, this method is
bestowed with several unique merits, such as the stability of the
substrates, cost-effectiveness and functional group tolerance.
Thus, we believe that this novel methodology will be a practical
alternative to existing procedures for the synthesis of bioactive
xanthones. Further studies on substrate scope and mechanism are
currently underway and will be reported in due course.
14. (a) Dubrovskiy, A. V.; Larock, R. C. Tetrahedron 2013, 69, 2789-2798;
(b) Dubrovskiy, A. V.; Larock, R. C. Org. Lett. 2010, 12, 3117-3119; (c)
Zhou, C.; Larock, R. C. J. Org. Chem. 2006, 71, 3551-3558.
15. (a) Yang, J.; Dong, C.; Li, H.; Li, H.; Li, Y. Chin. Sci. Bull. 2012, 57,
2364-2367; (b) Wertz, S.; Leifert, D.; Studer, A. Org. Lett. 2013, 15,
928-931; (c) Wang, P.; Rao, H.; Hua, R.; Li, C.-J. Org. Lett. 2012, 14,
902-905; (d) Hu, J.; Adogla, E. A.; Ju, Y.; Fan, D.; Wang, Q. Chem.
Commun. 2012, 48, 11256; (e) Menéndez, C. A.; Nador, F.; Radivoy, G.;
Gerbino, D. C. Org. Lett. 2014, 16, 2846; (f) Rao, H.; Ma, X.; Liu, Q.; Li,
Z.; Cao, S.; Li, C.-J. Adv. Synth. Catal. 2013, 355, 2191.
16. Zhang, H.; Shi, R.; Gan, P.; Liu, C.; Ding, A.; Wang, Q.; Lei, A. Angew.
Chem., Int. Ed. 2012, 51, 5204-5207.
Acknowledgments
17. Zhao, L.; Xie, F.; Cheng, G.; Hu, Y. Angew. Chem., Int. Ed. 2009, 48,
6520-6523.
Partial financial support from the Fundamental Research
Funds for the Central Universities in NWSUAF (2452013QN008)
and the National Natural Science Foundation of China (31301712)
is greatly appreciated. One of the authors would like to thank
Opening Funds of Key Laboratory of Synthetic Chemistry of
Natural Substances, Shanghai Institute of Organic Chemistry,
Chinese Academy of Sciences for the generous financial support
for funding this project. The authors are indebted to Prof F. W. Li
in Lanzhou Institute of Chemistry and Physics for applying the
idea.
18. (a) Roglans, A.; Pla-Quintana, A.; Moreno-Mañas, M. Chem. Rev. 2006,
106, 4622-4643; (b) Galli, C. Chem. Rev. 1988, 88, 765-792.
19. (a) Du, Z.; Zhou, J.; Si, C.; Ma, W. Synlett 2011, 3023-3025; (b) Zhou, J.;
Huang, L.-Z.; Li, Y.-Q.; Du, Z.-T. Tetrahedron Lett. 2012, 53, 7036-
7039; (c) Han, P.; Zhou, J.; Zhang, C. C.; Chen, K.; Du, Z. T.
Heterocycles 2014, 89, 2151-2160.
Supplementary Material
Supplementary material that may be helpful in the review
process should be prepared and provided as a separate electronic
file. That file can then be transformed into PDF format and
submitted along with the manuscript and graphic files to the
appropriate editorial office.
References and notes
1. Peres, V.; Nagem, T. J.; de Oliveira, F. F. Phytochemistry 2000, 55, 683-
710.